82296-10-4 Usage
Molecular Structure
Heterocyclic compound
The compound contains an imidazo[2,1-c][1,4]benzoxazine core, which is a heterocyclic structure consisting of a benzene ring fused with a benzoxazine ring and an imidazole ring.
Carboxylate Groups
Two
The compound has two carboxylate groups (-COO-) attached to the core structure, which contribute to its chemical reactivity and potential pharmacological properties.
Ethyl and Methyl Substituents
One each
The compound has an ethyl group (-C2H5) and a methyl group (-CH3) attached to the imidazo[2,1-c][1,4]benzoxazine core, which influence its chemical and physical properties.
Potential Applications
Medicinal chemistry and drug development
Due to its unique chemical structure, the compound may exhibit pharmacological properties that could be useful in the development of new medications.
Research Status
Requires further analysis
Although the compound has potential applications in medicinal chemistry, more research and analysis are needed to fully understand its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 82296-10-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,2,9 and 6 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 82296-10:
(7*8)+(6*2)+(5*2)+(4*9)+(3*6)+(2*1)+(1*0)=134
134 % 10 = 4
So 82296-10-4 is a valid CAS Registry Number.
82296-10-4Relevant articles and documents
Synthesis and Reactions of Some Novel Imidazobenzoxazines and Related Systems
Danswan, Geoff W.,Hairsine, Peter W.,Rowlands, David A.,Taylor, John B.,Westwood, Robert
, p. 1049 - 1058 (2007/10/02)
A novel synthesis of the new 4H-imidazobenzoxazine system (2) has been carried out under two sets of conditions, leading to products with differing functionalities.The effect of substituents on the cyclization step has been investigated and the reactions of the functional groups of the new ring system have been studied.Derivatives of the related 4,5-dihydroimidazobenzoxazepine (3) have also been prepared.